SCHEMBL21200769

SCHEMBL21200769

C=CC1=NC(=O)c2ccccc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
CDC25B P30305 2/20 0.36
MAOA P21397 3/20 0.35
APAF1 O14727 2/20 0.35
TDP2 O95551 2/20 0.35
KDM4E B2RXH2 1/20 0.35
CES2 O00748 1/20 0.35
TERT O14746 1/20 0.35
NPC1 O15118 1/20 0.35
PLIN1 O60240 1/20 0.35
S1PR4 O95977 1/20 0.35
LMNA P02545 1/20 0.35
PLA2G1B P04054 1/20 0.35
BCHE P06276 1/20 0.35
POLB P06746 1/20 0.35
PTPRC P08575 1/20 0.35
MAPT P10636 1/20 0.35
THRB P10828 1/20 0.35
PLCG1 P19174 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8346897 0.82 MEN1 (0.36) MEN1KMT2ACDC25BMAOAAPAF1
SCHEMBL21125960 0.77 ALDH1A1 (0.33) ALDH1A1TSHR
SCHEMBL29492985 0.67 CDC25B (0.39) MEN1KMT2ACDC25BMAOAAPAF1
SCHEMBL2359460 0.67 IDO1 (0.44) MEN1KMT2ACDC25BMAOAAPAF1
SCHEMBL879050 0.67 CDC25B (0.39) MEN1KMT2ACDC25BMAOAAPAF1
Phthalimide SCHEMBL1388700 0.67 APAF1 (0.44) MEN1KMT2ACDC25BMAOAAPAF1
SCHEMBL3697487 0.67 MEN1 (0.39) MEN1KMT2ACDC25BMAOAAPAF1
SCHEMBL2026326 0.67 MEN1 (0.39) MEN1KMT2ACDC25BMAOAAPAF1
SCHEMBL31131321 0.67 LMNA (0.45) MEN1KMT2ACDC25BMAOAAPAF1
SCHEMBL8026499 0.67 MEN1 (0.39) MEN1KMT2ACDC25BMAOAAPAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3743063-A1 INHIBITORS OF CBL-B AND METHODS OF USE THEREOF Nurix Therapeutics, Inc. (US) 2020-12-02 EP disclosed
WO-2019148005-A1 INHIBITORS OF CBL-B AND METHODS OF USE THEREOF NURIX THERAPEUTICS, INC. (US) 2019-08-01 WO disclosed